Biologics
Sanyou Bio Cheers KangaBio's IND Approval for Next-Gen IL-12 Prodrug Cancer Immunotherapy
These trials will primarily focus on late-stage solid tumors and the effectiveness will either be evaluated as a standalone therapy or in combination with ...
November 06, 2023 | News
Aquinnah Pharmaceuticals Advances Alzheimer's Tauopathy Program
Aquinnah Pharmaceuticals announced preclinical research findings for a novel therapeutic designed to slow or stop the progression of Alzheimer's disea...
October 31, 2023 | News
Merck Expands Oncology Pipeline with Hengrui Partnership for PARP1 Inhibitor and ADC
Collaboration to develop, manufacture and commercialize next-generation selective PARP1 inhibitor HRS-1167, with option to develop, manufacture and comme...
October 31, 2023 | News
Henlius Expands Partnership with Intas to Introduce Serplulimab in Europe and India
Intas to develop and commercialise serplulimab in Europe and India; Henlius to receive €42 million upfront payment, double-digit royalt...
October 30, 2023 | News
Exactech Announces Clearance for Its New 3D-Printed Vantage® Ankle Tibial Implants
The new implants provide orthopaedic surgeons with additional tibial height options for total ankle replacement patients. Both implants are 3D-printed and ...
October 27, 2023 | News
Chime Biologics and Hope Medicine Accelerate First-in-Class Antibody Drug HMI-115 for Endometriosis and Androgenic Alopecia
Chime Biologics to support the late-stage clinical study and to provide global commercial manufacturing services for Hope Medicine...
October 27, 2023 | News
Biotium Introduces New Highly-Selective Stains For Both Gram-Positive and Gram-Negative Bacteria
Biotium, a leading innovator of fluorescent dyes for life science research, proudly announces the launch of its breakthrough ...
October 26, 2023 | News
Lonza's Rapid PyroCell® Enhances Rabbit-Free Pyrogen Testing
Lonza launched PyroCell® MAT Rapid System and PyroCell® MAT Human Serum (HS) Rapid System, two sustainable monocyte activation test (MAT) systems...
October 25, 2023 | News
Polyplus Expands LipidBrick® Library to Optimize LNP Formulation for mRNA Therapeutics
LNPs have demonstrated high efficiency delivering RNA therapeutics in vivo, but they can be hard to modulate with challenges in the biodistributi...
October 25, 2023 | News
Australia's Certa Therapeutics: FT011 Granted US FDA Orphan Drug Status for Systemic Sclerosis
Orphan Drug Designation is granted by the FDA to investigational therapies addressing rare medical diseases or conditions that affect fewer than 200,000 pe...
October 24, 2023 | News
OBiO and Refreshgene Join Forces for Gene Therapy Product Commercialization
Under the agreement, OBiO leverages its capabilities of process development, large-scale cGMP commercial production and global business development to prov...
October 24, 2023 | News
Daiichi Sankyo and MSD Collaborate on Three Global DXd ADCs
Collaboration combines Daiichi Sankyo’s proven ADC expertise and DXd technology with MSD’s deep experience in oncology and clinical developme...
October 23, 2023 | News
FDA Approves PENBRAYA™: First Vaccine for 5 Common Meningococcal Serogroups in Teens
PENBRAYA™ provides the broadest serogroup coverage (meningococcal groups A, B, C, W and Y) of any meningococcal vaccine available in the U.S. ...
October 23, 2023 | News
Endeavor BioMedicines Licenses HER3-Targeted ADC Worldwide Rights from Hummingbird Bioscience
Endeavor obtains exclusive worldwide rights to Hummingbird Bioscience’s anti-HER3 ADC to be developed for patients with HER3-expressing tumors Hum...
October 20, 2023 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
